ImmunityBio

We are honored to join the urology community at the American Urological Association Annual Meeting as leaders across the field come together to advance the future of bladder cancer care.

At ImmunityBio, our work in the space is centered on exploring immunotherapy approaches for patients who continue to face complex treatment decisions. As new clinical insights and data continue to emerge, we aim to support a patient-centered strategy to care and ongoing conversations around the evolving treatment landscape.

Meaningful progress requires more than scientific innovation alone - it takes continued collaboration across the urology collective, with a shared focus on improving outcomes for patients.